PubMed Health⌕ Search

Biomedical subjects

G A Pepper

Publications and source records attributed to G A Pepper.

At least 19 recordsLinked to original sources

Nonsteroidal anti-inflammatory drugs: new perspectives on a familiar drug class.

Nonsteroidal anti-inflammatory drugs are among the most commonly used and lethal drug classes. The anti-inflammatory, analgesic, and antipyretic effects result from the inhibition of cyclooxygenase (COX), which is the critical enzyme in the synthesis of prostaglandins. The most common adverse effects are gastrointestinal, but renal and platelet effects are also important. Recent discovery that there are two forms of cyclooxygenase (COX-1 and COX-2) has led to hypothesis that the newly marketed COX-2 selective inhibitor can provide beneficial effects without these adverse effects. Patient monitoring and education are nursing functions essential to the safe use of these agents.

Analgesia↗

Preventing myocardial infarction: cholestyramine (Questran) and other hypolipidemics.

For decades the association between serum cholesterol and atherosclerotic heart disease has been recognized; the higher an individual's serum cholesterol concentration, the greater the risk of myocardial infarction and other manifestations of coronary artery disease. Many of the hypolipidemics (drugs that reduce levels of lipids in the blood) have been available for more than 10 years, but only last year was one of these agents, cholestyramine (Questran), approved for use in the prevention of coronary heart disease. The purposes of this article are to describe the events that led to the approval of this indication for cholestyramine (but not for the other hypolipidemics), to explore the factors that primary health care practitioners should consider in the management of hypercholesterolemia and to anticipate future developments in hypolipidemic therapy.

Cholestyramine Resin↗